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Abstract
T cell paralysis is a main feature of measles virus (MV) induced immunosuppression. MV contact mediated activation of
sphingomyelinases was found to contribute to MV interference with T cell actin reorganization. The role of these enzymes in
MV-induced inhibition of T cell activation remained equally undefined as their general role in regulating immune synapse
(IS) activity which relies on spatiotemporal membrane patterning. Our study for the first time reveals that transient
activation of the neutral sphingomyelinase 2 (NSM2) occurs in physiological co-stimulation of primary T cells where
ceramide accumulation is confined to the lamellum (where also NSM2 can be detected) and excluded from IS areas of high
actin turnover. Genetic ablation of the enzyme is associated with T cell hyper-responsiveness as revealed by actin dynamics,
tyrosine phosphorylation, Ca2+-mobilization and expansion indicating that NSM2 acts to suppress overshooting T cell
responses. In line with its suppressive activity, exaggerated, prolonged NSM2 activation as occurring in co-stimulated T cells
following MV exposure was associated with aberrant compartmentalization of ceramides, loss of spreading responses,
interference with accumulation of tyrosine phosphorylated protein species and expansion. Altogether, this study for the first
time reveals a role of NSM2 in physiological T cell stimulation which is dampening and can be abused by a virus, which
promotes enhanced and prolonged NSM2 activation to cause pathological T cell suppression.
Citation: Mueller N, Avota E, Collenburg L, Grassme´ H, Schneider-Schaulies S (2014) Neutral Sphingomyelinase in Physiological and Measles Virus Induced T Cell
Suppression. PLoS Pathog 10(12): e1004574. doi:10.1371/journal.ppat.1004574
Editor: Paul G. Thomas, St. Jude Children’s Research Hospital, United States of America
Received July 3, 2014; Accepted November 12, 2014; Published December 18, 2014
Copyright:  2014 Mueller et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its
Supporting Information files.
Funding: The study was supported by the Deutsche Forschungsgemeinschaft (Research Unit 2123 (SCHN 405/9); NM: MU 3205/1-1, SSS: SCHN 405/10-1, HG: GR
1697/2-1). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access
Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors declare that no competing interests exist.
* Email: s-s-s@vim.uni-wuerzburg.de
. These authors contributed equally to this work.
Introduction
Plasma membrane ceramides are released in response to
activation of sphingomyelinases and condense into large platforms
which alter biophysical properties of the cell membrane. In
addition to other stimuli, ligation of certain surface molecules, also
including death receptor family members and viral attachment
receptors, efficiently activates neutral and/or acid sphingomyelin-
ase (NSM or ASM, respectively) followed by ceramide release
(reviewed in [1–3]). Ceramide enriched membrane microdomains
act to regulate sorting of membrane proteins and their signalo-
somes, and this affects a variety of biological responses including
lateral and vertical receptor segregation as particularly relevant for
pathogen uptake, apoptosis, cell motility and proliferation [3–6].
Measles virus (MV) causes profound generalized immunosup-
pression and interference with T cell viability, expansion and
function is one of its major hallmarks. A plethora of findings
supports the interpretation that MV is acquired and transferred by
CD150+ antigen-presenting cells to the secondary lymphatic
tissues where it can be transmitted to and deplete CD150+
lymphocytes, especially memory T cells [7–9]. Though being
infected to a very limited extent, peripheral blood cells of patients,
however, are generally refractory to expansion driven by
polyclonal and antigen-specific stimulation, implying they had
been paralysed by mechanisms independently of direct infection.
In line with this hypothesis, exposure of uninfected lymphocytes to
UV-inactivated MV or the MV glycoprotein complex (gpc) was
sufficient to induce their arrest in vitro and in vivo [10–13]. For
this, the gpc interacts with an as yet unknown receptor on the
surface of T cells (which is not identical to CD150 [14]) to
abrogate relay of T cell receptor (TCR) signaling at the level of the
phosphatidyl-inositol-phosphate-3-kinase (PI3K) and its down-
stream effectors, Akt kinase, Vav1, Rac1 and Cdc42 [15–17].
Because these are also major regulators of actin cytoskeletal
dynamics, MV contact induced physical T cell paralysis is reflected
by collapse of actin based protrusions and loss of polarity and
motility on fibronectin [15–18]. Thus, by targeting the PI3K, MV
abrogates activation of downstream effectors essentially mediating
S-phase progression, but also actin dynamics which is of key
importance in organizing the functional architecture of the
immune synapse (IS) where T cell signaling is initiated and
sustained [19].
In order to interfere with TCR signaling, MV has to initiate
signaling upon binding to T cells itself. This involved sequential
activation of NSM2 (the NSM species abundant at the plasma
membrane) and ASM, which almost entirely accounted for MV
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interference with actin cytoskeletal integrity and dynamics [18],
though the role of sphingomyelinase activation on T cell activation
remained unknown.
The role of ceramide release in regulating T cell activation by
CD3/CD28 co-stimulation is unclear. Ligation of either CD3 or
CD28 alone caused activation of NSM or ASM, respectively
[20,21]. CD3-mediated NSM activation was dispensable for TCR-
induced overall tyrosine phosphorylation, however, required for
IL-2 production and MAPK activation [20], while ASM-mediated
ceramide release was important for CD28-dependent NF-kB
activation [21]. In the latter study, exogenous supply of ceramides
fully replaced ASM activity in co-stimulation. In contrast, other
studies indicated an inhibitory activity of ceramide in co-
stimulating CD3 signaling [22–24], and ceramide metabolites
are of low abundance in CD3 associated domains immuno-
isolated from T cells following activation [25]. This indicates that
sphingomyelin breakdown, if occurring at all, has to be tightly
controlled and compartmentalized at the level of the IS, and, if
aberrantly induced, might translate into T cell inhibition.
With the present study we addressed activation of sphingomyelin-
ases and subcellular distribution of ceramide accumulation upon
CD3/CD28 co-ligation. Strikingly, co-stimulation entirely abrogated
ASM activation while caused an early rise in NSM activity. This
proved to be important for dampening thresholds of T cell activation
because cell spreading as required for formation of IS interaction
platforms and overall tyrosine phosphorylation were initiated earlier
and were enhanced upon NSM knockdown as was expansion of T
cells. Enhancement of sphingomyelinase activity upon pre-exposure
to MV was associated with accumulation of ceramide enriched
membrane domains at the synaptic interface. Importantly, MV
induced NSM activation substantially accounted for loss of spreading
responses and partially for MV interference with TCR-induced
tyrosine-phosphorylation and expansion. Altogether, our findings
indicate that the ability of NSM to dampen the threshold of T cell
activation is exploited by MV for T cell suppression.
Results
Sphingomyelinase activation and ceramide release are
tightly controlled in T cell co-stimulation
CD28 ligation causes ASM activation followed by ceramide
release [21], which can be inhibitory to T cell stimulation [23,24].
We therefore investigated whether CD3/CD28 co-stimulation
would also promote ASM activation in primary T cells. Using a
planar system (plate bound antibodies) for stimulation, ligation of
CD28 alone (but not that of CD3) expectedly induced ASM
activity which peaked after 15 min. This, was, however,
completely abrogated upon CD3/CD28 co-stimulation where
ASM activity did not significantly increase during the observation
period (Fig. 1A). Activated ASM is the major source of extrafacial
ceramide, and consequently, ceramide was displayed at the cell
surface following ligation of CD28, but not of CD3 or CD3/CD28
co-ligation on T cells as detected by flow cytometry. This again
supported the interpretation that CD28-mediated ASM activation
is abolished upon co-stimulation (Fig. 1B, and S1A Fig.). Because
NSM2 activation after CD3 ligation and cross-regulation of
sphingomyelinases have been described earlier [18,20,26], we
analyzed whether NSM2 would be involved in ASM inhibition by
knocking down NSM2 in T cells by specific siRNA (further
referred to as NSMKD T cells) (Fig. 1C). In contrast to what has
been reported for other cell types [26], NSM knockdown did not
augment basal ASM activity (S1B Fig.). As measured in co-
stimulated untransfected T cells (Fig. 1A), the ASM activity
remained at or below basal levels in control siRNA transfected
cells (further refered to as CTRL T cells) (Fig. 1D, left panel). In
NSMKD T cells, biphasic activation of the enzyme occurred to
levels comparable to those measured upon CD28 ligation (Fig. 1A
and 1D, left panel) indicating that NSM activity was required to
extinguish that of ASM in co-stimulation. ASM activity was
enhanced in NSMKD T cells, however, accumulation of
extrafacial ceramides was not and rather remained at levels below
that of CTRL T cells (Fig. 1D, right panel). In line with previous
findings [20], early NSM activation in response to CD3 ligation
did occur in untransfected T cells, and did not significantly differ
from that induced upon co-stimulation, while a late peak of NSM
activation was only seen after CD3 ligation (Fig. 1E). As revealed
by direct comparison of activities of both enzymes, ASM
activation does not occur in co-stimulated T cells while NSM
was transiently activated clearly exceeding background levels,
retained within 15 minutes and dropped thereafter (Fig. 1F). To
the best of our knowledge, cross-regulation of ASM and NSM
upon co-stimulation of receptors individually promoting their
activation has not been previously observed.
Ceramide enriched membrane domains are confined to
the lamellum where NSM2 is co-detected
Cross-regulation of ASM and NSM activity upon co-stimulation
implies that activation of these enzymes and ceramide release have
to be limited, tightly controlled and eventually compartmentalized
during T cell activation. To assess the latter question directly, we
co-detected ceramide with f-actin in T cells seeded onto co-
stimulatory slides after 10 min. After this period, cells had spread
on the planar support with typical IS formation where lamellum
(corresponding to the pSMAC where centripetal transport of
microclusters occurs), lamellipodium (corresponding to the
dSMAC with particularly high actin dynamic reorganization) (as
detected by f-actin, Fig. 2A) and the actin-free cSMAC (where
TCR activity is terminated) can be visualized (Fig. 2A). Most
interestingly, ceramide-enriched membrane domains were virtu-
ally absent from the lamellipodium, while they were readily
detectable within the lamellum (Fig. 2A). Analyses addressing the
subcellular distibution of NSM2, the enzyme most likely involved
in generating ceramides at the IS (Fig. 1F), could not be performed
in fixed cells using antibodies because commercially available
NSM-antibodies revealed a broad reactivity in Western blot
analyses rendering them unsuitable to obtain reliable staining
Author Summary
Though the ability of measles virus (MV) to impair T cell
activation has long been known, it is mechanistically not
well understood. We have shown earlier that MV can
contact dependently trigger activation of sphingomyelin-
ases which is known to affect compartmentalization of
membrane lipids and proteins. Because these are partic-
ularly important in the activity of the immune synapse (IS),
we investigated whether MV-induced sphingomyelinase
activity would interfere at that level with T cell activation.
Our study for the first time revealed that the neutral
sphingomyelinase 2 (NSM2) is transiently activated in
primary T cells by co-stimulation through CD3 and CD28,
and that this does occur to dampen early T cell responses.
The virus appears to exploit this inhibitory activity of the
enzyme to suppress T cell activation by promoting an
enhanced and prolonged NSM2 activation. These findings
do not only assign a hitherto novel role of the NSM2 in
regulating T cell responses, but also reveal a novel strategy
for viral T cell suppression.
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Fig. 1. ASM activation is ablated, while NSM activity is induced early in co-stimulated primary human T cells. A. ASM activity was
determined in membrane extracts of T cells activated by a-CD28, a-CD3 or a-CD3/CD28 over time. B. Surface ceramide was detected on T cells
activated by ligation of CD3, CD28 or CD3/CD28 by flow cytometry C. NSM activity in membrane extracts of T cells 96 h following transfection of
control (CTRL) or NSM2 siRNA (NSMKD). D. ASM activity in membrane extracts of aa˜CD3/CD28 co-stimulated T cells (left) and extrafacial ceramide
display (FACS staining) (right, upper graphs: unstimulated, CTRL or NSMKD T cells, upper right corner values represent mean fluorescence intensities;
bottom graph: kinetics of ceramide surface display on CTRL versus NSMKD co-stimulated T cells. E. NSM activity was determined in membrane
extracts of T cells activated by a-CD28, a-CD3 or a-CD3/CD28. F. ASM and NSM activity were determined over time in a-CD3/CD28 co-stimulated T
cells.
doi:10.1371/journal.ppat.1004574.g001
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patterns. We therefore analyzed NSM2 distribution following
nucleofection of GFP-tagged neutral sphingomyelinase [27]. As for
ceramide, NSM2-GFP appeared to localize mainly to the
lamellum (Fig. 2B). However, the enzyme was not entirely absent
from the lamellipodium and the cSMAC (Fig. 2B, 3D reconstruc-
tion). Also of note, although the protein expressed well in other cell
types ([27,28] and 293 cells, not shown), expression levels of
NSM2-GFP in T cells were low Fig. 2B, second panel). Altogether,
these data reveal that NSM, but not ASM activation does occur
early during co-stimulation, however, ceramide release is spatially
confined and excluded from areas of high actin activity.
NSM deficiency renders T cells hyper-responsive to
stimulation
Early NSM activation during co-stimulation suggested that the
enzyme may have a role in T cell activation. To address this, we
comparatively analyzed parameters important in early T cell
activation in CTRL and NSMKD T cells (which did not
detectably differ with regard to surface expression of CD3 or
CD28, S1C Fig.). When seeded onto co-stimulatory slides,
NSMKD T cells more efficiently adhered and spread than CTRL
T cells already after 5 min (Fig. 3A). 10 min following activation
(when comparable amounts of CTRL T cells had adhered)
NSMKD T cells revealed an enhanced spreading response
acquiring extended cell areas framed by actin-dense lamellipodial
extensions. Moreover, they detectably polarized (usually repre-
senting late stages of activation) giving rise to extended protrusions
20 or 60 min following activation (Fig. 3B). These observations
were confirmed by scanning electron microscopy analyses, where
NSMKD T cells acquired a flattened, lamellar appearance tightly
interacting with the planar support already 10 min following
stimulation, which was seen in CTRL T cells only after 60 min.
Remarkably, at that time NSMKD, but not CTRL T cells, had
developed veil like protrusions indicative for acquisition of a more
motile phenotype (Fig. 3C, arrows, and S2A Fig.). This indicates
that T cell activation occurs more rapidly upon NSMKD and is
associated with enhanced actin cytoskeletal activity. Moreover,
accumulation of tyrosine phosphorylated protein species (p-tyr), p-
ERK and p-Akt was accelarated and enhanced in NSMKD T cells
as was initiation and magnitude of Ca2+-fluxing indicating that
NSM depletion facilitated early T cell activation (Fig. 3D and, for
overall p-tyr, Fig. 6A). Importantly, this also translated into
proliferative responses of NSMKD T cells which expanded
significantly more efficient in response to CD3/CD28 ligation
than CTRL T cells. As seen for spreading responses, NSMKD also
appeared to especially support early expansion of co-stimulated T
cells (Fig. 3E, left panel, 48 h). As for human cells, proliferation of
splenocytes isolated from Smpd3 deficient fro/fro mice driven by
syngenic, superantigen-loaded bone marrow derived DCs was
significantly enhanced as compared to that of Smpd3 sufficient
littermates (Fig. 3E, right panel). In contrast to expansion, neither
release of cytokines (IL-2, IL-4, IL-5, IL-10, IFN-c or TNF-a) 4,
10, 24 or 72 h following a-CD3/CD28 stimulation or intracellular
accumulation of IL-2, IL-10, IFN-c or IL-17a) following a 4 h
restimulation were detectably affected by NSM knockdown in
human T cells (not shown). Altogether, these observations suggest
that NSMKD facilitates initiation of T cell activation and
Fig. 2. Ceramide and NSM2 accumulate within the lamellum in co-stimulated T cells. A. Ceramide and f-actin were co-detected in T cells
15 min after seeding onto co-stimulatory slides (left panels, with intensities indicated by false colour representation, bottom panels). Size bar: 5 mm.
Subcellular distribution of actin (in red) and ceramide (in green) within the lamellum (LM) or the lamellipodium (LP) are representatively shown as
profiles (middle panel, intensity profile plane indicated by the arrow) or blow ups imaged at lower or higher z planes (distance approximately
600 nm)(right panels, enlargements of boxed area middle panel). B. NSM2 and f-actin were co-detected 24 h following nucleofection of p-NSM2-GFP
(NSM2: green, f-actin: red). Subcellular distribution of NSM2-GFP is shown after deconvolution and 3D reconstruction (right panel). Size bar: 5 mm.
doi:10.1371/journal.ppat.1004574.g002
Measles Virus Exploits NSM for T Cell Suppression
PLOS Pathogens | www.plospathogens.org 4 December 2014 | Volume 10 | Issue 12 | e1004574
Measles Virus Exploits NSM for T Cell Suppression
PLOS Pathogens | www.plospathogens.org 5 December 2014 | Volume 10 | Issue 12 | e1004574
therefore, NSM activity acts to dampen early T cell activation
thresholds.
MV exposure alters ceramide and NSM
compartmentalization at stimulatory interfaces
If NSM activity regulates the initiation threshold of physiolog-
ical T cell activation, conditions additionally enhancing NSM
activity could possibly further dampen T cell activation by
promoting timely or spatially aberrant ceramide release. MV is
known as an efficient inhibitor of T cell activation and its ability to
cause sequential NSM/ASM activation in these cells has been
established by us earlier [18]. In line with our previous findings,
MV caused NSM activation in T cells (Fig. 4A). When compared
to NSM activity induced upon co-stimulation alone, that induced
upon additional MV exposure was elevated and persisted
indicating that MV supports exaggerated and sustained NSM
activation during T cell activation. Because studies involving
bacterial sphingomyelinase (bSMAse) or short to middle chain
ceramides suggested an inhibitory activity of ceramides in T cell
stimulation [23,24], we assessed whether augmented NSM
activation would affect subcellular redistribution of ceramides.
When exposed to bSMase or MV (both of which caused
comparable ceramide release within 20 min, S3A Fig.), T cells
barely adhered and spread on co-stimulatory slides (S2B Fig.).
Because of the substantial differences in cell areas, it was not
possible to evaluate whether the apparent central concentration of
ceramide clusters in bSMase or MV pre-exposed cells resulted
from condensation of the contact plane or mis-localization of
ceramides (Fig. 4B). As an alternative approach, we analyzed
ceramide accumulation at interfaces formed between T cells pre-
exposed to MV and co-stimulatory beads coated with CD3/
CD28-specific antibodies. In line with our observations made in
the planar system (Fig. 2A and 4B), ceramides were largely
excluded from the center of the interfaces formed with MOCK
treated T cells, and this was unaffected by NSMKD (Fig. 4C). As
revealed for adhesion to other supports, MV pre-exposure
impaired adhesion of CTRL T cells and thereby the frequency
of conjugates with beads (not shown). A substantial fraction of
conjugates, that did form with MV-exposed CTRL T cells,
however, did not efficiently exclude ceramide from the interface,
which was, however, entirely corrected for in NSMKD T cells
(Fig. 4C). Thus, MV-induced NSM activation is followed by mis-
compartmentalization of ceramide within the IS. To address
whether NSM is also excluded from the IS center in this system,
and if so, wether this is altered in MV-exposed T cells, we studied
distribution of the enzmye in bead assays involving NSM-GFP
expressing T cells. In MOCK treated cells, NSM-GFP was
detected in association with the plasma membrane, but also with
intracellular, presumably Golgi, compartments as described
previously for MCF-7 cells [28] (Fig. 4D). Interestingly, these
efficiently polarized to the distal pole of the T cell while NSM-GFP
was mainly excluded from the bead interface (Fig. 4D, upper
panel). In MV-exposed cultures, T cells remained mainly round
and failed to detectably polarize which also referred to the
localization of the intracellular NSM-GFP enriched compartments
(Fig. 4D, bottom panels and S2 Fig.). As seen for ceramides,
NSM2 was not efficiently excluded from the interfaces involving
MV-pre-exposed T cells indicating that MV signaling interferes
with compartmentalization of both NSM2 and ceramides in the
IS.
NSM ablation corrects for MV-induced interference with
T cell adhesion and spreading. In order to identify potential
targets of MV-induced NSM activation in T cell suppression, we
comparatively analyzed actin dependent spreading responses of
CTRL and NSMKD T cells. As seen with co-stimulatory beads,
MV pre-exposure interfered with adhesion of CTRL, but not
NSMKD T cells, which expectedly, adhered more efficiently
(Fig. 5A, compare also Fig. 3A). When cell areas of CTRL or
NSMKD T cells pre-exposed to MV or MOCK were compar-
atively analyzed, genetic NSM ablation slightly, yet detectably
resulted in increased cell areas as also noted earlier (Fig. 3, 5A,
bottom graph, and S2B Fig.). MV caused a prominent reduction
in cell area in CTRL T cells, however, not in NSMKD cells
indicating that MV-induced loss of spreading responses was
dependent on NSM activation by the virus (Fig. 5A). This
interpretation was confirmed upon pharmacological inhibition of
NSM by GW4869 where MV treatment substantially reduced the
mean cell area in untreated, but not inhibitor pre-exposed T cells
as also reflected by redistribution of f-actin and LAT clusters
(Fig. 5B, upper panels and graph). Short term exposure to
dexamethasone activates NSM2 in other cell types [29], and this
is also true for primary T cells where spreading responses are
affected upon dexamethasone exposure (S3B Fig.) further
supporting the role of this enzyme in this activation parameter
also induced by the virus.
NSM activation contributes to MV interference with T cell
activation and expansion
To evaluate whether defective spreading responses were
associated with impairments of T cell activation, accumulation
of tyrosine phosphorylated protein species (p-tyr) indicating
relay of TCR signaling in response to a-CD3/CD28 stimula-
tion were analyzed in NSMKD T cells pre-exposed to MV or
MOCK. In CTRL T cell cultures, MV exposure appeared to
compromize accumulation of certain, yet not all p-tyr protein
species as compared to MOCK-treated cells (Fig. 6A, left,
asterisks). NSM knockdown substantially increased accumula-
tion of p-tyr protein species in MV exposed cells (NSMKD+
MV), which, however, still remained below the levels seen in
MOCK-treated NSMKD T cells which by far exceeded those
seen in CTRL T cell cultures (Fig. 6A, right panel). These data
support the overall importance of NSM activity in down-
modulating initiation of T cell activation (Fig. 3), but also
reveal that MV mediated NSM activation contributes to
alterations seen with regard to p-tyr accumulation after TCR
triggering. To study the impact of NSM activation on MV-
Fig. 3. NSM acts to dampen initiation of T cell activation. A–C. T cells transfected with NSM2 (NSMKD) or control siRNA (CTRL) were seeded
onto co-stimulatory slides and analyzed for f-actin distribution (A, B), adherence (A), cell area (A, B) and formation of extended lamellar protrusions (C)
after 5 min (A) or the time intervals indicated (B,C) by confocal (A, B) or scanning electron microscopy (C; veils marked by arrowheads; at least 50 cells
were recruited per culture into the analysis). Representative examples of the quantitative analyses are depicted in the left panels. Size bars: A, B:
10 mm, C, 1 mm. D. Left panels: pERK or pAkt induction following aa˜CD3/CD28 activation (min) in CRTL and NSMKD T cells (signals for pAkt and pERK
and the respective protein loading controls were quantified by AIDA software and are expressed as ’fold induction’, middle panels) Right panel: Ca2+
mobilization was determined over time in NSMKD (open histogram) versus CTRL T cells (filled histogram) following a-CD3/CD28 activation by flow
cytometry. Representative examples out of at least each 3 are shown. E. Proliferative responses of human primary NSMKD (white bars) or CTRL T cells
(black bars) 48 h and 72 h following aa˜CD3/CD28 activation (left panel) or Smpd3-deficient or –sufficient mouse splenocytes 72 h following co-
culture with syngenic, superantigen-loaded bone marrow derived DCs (right panel).
doi:10.1371/journal.ppat.1004574.g003
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Fig. 4. MV causes early superactivation of NSM and ceramide accumulation within stimulatory interfaces. A. NSM activity was
determined in membrane extracts isolated from T cells exposed to MV or MOCK prior to aa˜CD3/CD28 activation for the time intervals indicated. Time
point ’0 and 15 min’ (right) measured NSM activity in T cells exposed to MV but not stimulated by aa˜CD3/CD28 ligation. B. Ceramide (green) and f-
actin (red) were detected in T cells pre-exposed to bSMase, MOCK or MV and seeded onto co-stimulatory slides for 15 min. Representative examples
of 50 cells analyzed per culture are shown after 3D deconvolution. C. The percentage of conjugates excluding ceramide from the interface between
aa˜CD3/CD28 coated beads (marked by asterisks) and CTRL or NSMKD T cells pre-exposed to MV or MOCK was determined 15 min following
conjugate formation, fixation and staining by a-ceramide antibody. D. 24 h following p-NSM2-GFP nucleofection, T cells were exposed to MOCK or
MV, conjugated to aa˜CD3/CD28 coated beads and the frequency of conjugates excluding NSM2-GFP from the interface in both cultures was
Measles Virus Exploits NSM for T Cell Suppression
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induced inhibition of stimulated T cell expansion, NSMKD
and CTRL T cells were exposed to MV (or the corresponding
amounts of MOCK) and proliferation was analyzed 48 h
following aa˜CD3/CD28 stimulation. MV dose dependently
inhibited T cell expansion both in CTRL and NSMKD T cells,
however, the latter expanded substantially more effective
indicating that NSM ablation enables high proliferative
activity in spite of MV inhibitory signaling (Fig. 6B). There-
fore, NSM activation by MV contributes, however, not fully
accounts for MV T cell inhibition. Altogether, these findings
determined. C, D: Left panels show examples for interface exclusion/inclusion (boxed areas), at least 100 conjugates/per culture were recruited for
quantitation in three independent experiments. DIC: differential interference contrast. Size bars: A, B: 5 mm, C: 10 mm.
doi:10.1371/journal.ppat.1004574.g004
Fig. 5. MV-mediated NSM activation accounts for the loss of spreading responses. Cell areas were determined in T cells where NSM
activity was genetically (NSMKD, A) or pharmacologically (pre-exposure to GW4869, B) ablated prior to MOCK or MV exposure and subsequent
seeding onto co-stimulatory slides for 15 min. Spreading responses were detected by staining for f-actin alone (A) or co-detection with LAT used to
detect microclusters (B). Frequencies of CTRL or NSMKD cells adhering to the co-stimulatory slides after exposure to MV or MOCK were determined
(A). Size bars: A, B: 5 mm.
doi:10.1371/journal.ppat.1004574.g005
Measles Virus Exploits NSM for T Cell Suppression
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suggest that NSM activation during TCR triggering acts to
dampen T cell activation, which, when inappropriately
elicited, results in T cell suppression.
Discussion
Using siRNA mediated genetic NSM ablation, our present
study reveals the hitherto unknown activity of the enzyme to
dampen the activation of co-stimulated T cells. This is because T
cell adhesion, spreading, actin cytoskeletal dynamics, accumula-
tion of tyrosine phosphorylated protein species and expansion are
significantly enhanced upon NSM knockdown (Fig. 3, 5–7). At the
subcellular level, accumulation of ceramide enriched membrane
domains is compartmentalized within the lamellum, whereas
ceramides appear to be excluded from the IS center and the
lamellipodium (Fig. 2). Indicating that MV exploits and augments
the dampening activity of NSM to interfere with T cell activation,
MV exposure causes substantial accumulation of ceramide within
the IS. This and MV-induced loss of adhesion and spreading
responses, is entirely, while MV-interference with p-tyr and T cell
expansion are partially rescued upon NSM ablation (Fig. 7).
Unfortunately, it is impossible to evaluate the role of the enzyme in
MV immunosuppression in vivo. Firstly, mice are not permissive
for peripheral MV infection and therefore cannot be used to study
MV T cell paralysis, and secondly, Smpd3 deficient animals (also
referred to as fragilis ossium (fro/fro) mice) suffer from severe
chondrodysplasia and dwarfism which, together with their low
birth frequencies (90% of the embryos are lost prenatally)
precludes infection experiments [30–32].
Ceramide enriched microdomains usually generated in response
to stimulated activation of sphingomyelinases and subsequent
sphingomyelin breakdown are sites of lateral protein segregation
also including receptors and associated signalosomes [3,33,34].
Both phenomena efficiently regulate cellular responses to exoge-
nous triggers in a variety of cells also including T lymphocytes
where relay of extracellular cues translates into regulation of
Fig. 6. NSM activation contributes to MV interference with T cell early activation and expansion. A. Overall tyrosine phosphorylation was
determined at the time intervals indicated following aa˜CD3/CD28 activation in CTRL and NSMKD cells pre-exposed to MOCK or MV (MOI 1,2) by
Western Blotting (where GAPDH detection served as loading control). p-tyr protein species detectably affected by MV interference are starred (*).
Right: densitometric analysis of p-tyr profiles of all p-tyr species was performed for each individual lane, quantified using AIDA software and
standardized to the signal intensities in unstimulated MOCK treated cells. B. Proliferation efficiencies of CTRL and NSMKD cells pre-exposed to MOCK
(each: white symbols) or MV (each: black symbols) at the MOIs indicated (or corresponding protein amounts of MOCK) were determined after 48 h by
incorporation of [3H]-thymidine.
doi:10.1371/journal.ppat.1004574.g006
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motility, adhesion and activation all of which are associated with
massive reorganizations of the cytoskeleton and signalosome
complexes [19,35]. The role of sphingomyelinases and ceramide
release early in TCR activation remained, however, controversal.
While confirming earlier finding that CD3 ligation alone causes
NSM activation which peaked late after activation [20], we found
that co-stimulation resulted in an early rise of the NSM activity
which subsequently returned to background levels. Thus, NSM
activity upon CD3/CD28 co-ligation is timely restricted and not
prolonged within the first 30 min of stimulation (Fig. 1). As
reported earlier [21], ligation of CD28 alone induced ASM and
surface ceramide display. This was, however entirely ablated upon
co-ligation (Fig. 1), indicating that ASM activity is dispensable for
early T cell activation. In line with this, ASM activation or
exogenous ceramide supply were not required for or even
inhibitory to early TCR signaling and co-stimulation [22,23].
Indicating that ASM activity interferes with T cell activation,
abrogation of TCR-stimulated Ca2+ mobilization following CD95
or TNFR-ligation was attributed to ASM activation [18,36,37]. In
contrast, ASM activation has also been reported to be beneficial
for CD28-mediated NF-kB activation or discharge of cytokines
from T cells [22,38]. In co-stimulated cells, early ASM activation
did not occur (Fig. 1), and we did not detect any significant impact
on NSM ablation on accumulation levels of the cytokines
measured intracellularly or in supernatants (not shown). Though
NSMKD clearly enhanced kinetics of early T cell activation,
activation of CTRL cells to comparative levels occurred (though
with delay, Fig. 3,6) and therefore, NSM relating alterations of late
activation functions such as cytokine production might not be
highly pronounced. Moreover, to the best of our knowledge,
except for its role in exosome production [39–41], a role of NSM
in vesicular trafficking and or discharge of vesicular compartments
has so far not been revealed.
NSM/ASM cross-regulation has been reported earlier. Asm was
substantially elevated at RNA, protein and activity level in
fibroblasts of Smpd3-deficient fro/fro mice in the absence of
stimulation [26], which was, however, not the case for NSMKD T
cells (S1B Fig.). In MV exposed T cells, NSM activity was required
for ASM activity triggered by the virus via an unknown receptor
[18]. It is beyond the scope of this study to unravel mechanisms
underlying NSM/ASM crossregulation in our system, which,
however, describes the first example of crossregulation by a
receptor complex.
By revealing that NSM ablation clearly had an enhancing effect
on steady state actin dynamics, early TCR signaling and
expansion, we established the role of the enzyme in regulating
kinetics and magnitude of T cell activation (Fig. 3, 6, 7). In
contrast to enhanced proliferative responses seen in NSMKD or
Smpd3-deficient splenocytes, re-introduction of Smpd3 corrected
for a strongly impaired cell cycling of Smpd3-deficient fro/fro
Fig. 7. Model of NSM-dependent T cell suppression. T cell co-stimulation induces transient activation of the NSM which, as ceramides, is
confined at early stages to the lamellum (upper graph, black line, left sketch of the T cell IS). In the presence of MV, NSM is activated more rapidly and
prolonged, and ceramides are not excluded from the IS center (upper graph, red line, right sketch of the T cell IS). Based on genetic ablation studies,
under physiologic conditions, the NSM appears to dampen overshooting T cell activation by regulating the speed of early T cell activation as defined
by the typical parameters listed. When inappropriately (time, magnitude) activated as occurring by MV T cell contact, the dampening role of NSM is
exaggerated and associated with actin cytoskeletal paralysis, but also contributes to MV-induced loss of certain p-tyr protein species and expansion.
Therefore, the ability of MV to cause NSM induction in a contact dependent manner accounts for major features of MV-mediated T cell suppression.
doi:10.1371/journal.ppat.1004574.g007
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fibroblasts [26] indicating that either compartmentalized receptor-
mediated activation or cell type specificity defines the impact of
NSM on proliferation. In line with our observations made with
regard to an inhibitory role of the enzyme in T cells, choleratoxin
B mediated inhibition of human CD4 cell proliferation has been
related to activation of NSM in lipid rafts [42]. Notably, however,
reduced ceramide levels in fro/fro fibroblasts were associated with
elevated PI3K activity and p-Akt levels indicating a role of NSM in
general prevention of activated cellular steady state [43]. In line
with this, NSM ablation in T cells elevated basal levels of p-tyr
prior to aa˜CD3/CD28 stimulation (Fig. 6).
Molecular targets of NSM in physiological T cell activation
remain unclear. As obvious from the p-tyr analysis, ablation of the
enzyme enhanced both kinetics and magnitude of signaling
responses which arguably might reflect its role in regulating
compartmentalization of signaling microclusters rather than
specific downstream targets (Fig. 6). Confinement of ceramides
and the the majority of the NSM2 to the lamellum where
actomyosin dynamics regulates microcluster transport might
indicate a role in communication with cytoskeletal adaptors
[44,45]. In turn, ceramide exclusion from the lamellipodium
would be compatible with the requirement of sphingomyelin
rather than ceramide at areas of high actin turnover [18,46,47].
When overexpressed in MCF-7 cells, a NSM-GFP pool was found
to shuttle from the Golgi to the plasma membrane [28]. Similarly,
a fraction of NSM appeared to be redistributed from a perinuclear
compartment upon T cell stimulation, and, most interestingly, late
after stimulation, to be segregated from the IS towards the distal
pole altogether indicating that trafficking of this enzyme during T
cell activation is tightly controlled (Fig. 4D). Mechanisms under-
lying NSM trafficking are, however, unknown as yet.
Both ceramides and NSM are excluded from the IS center upon
physiological TCR activation, and strikingly, ceramides and
NSM2 were shifted to the central IS upon pre-exposure to MV
prior to stimulation (Fig. 4C, D). Though this was entirely
corrected for by NSM ablation, we cannot rule out that ceramide
release there reflected aberrant activation of ASM as found to be
activated in MV exposed cells- [18].
Rescue of MV-induced ceramide mis-localization, loss of
adhesion and spreading responses by NSM ablation identifies
the enzyme as of key importance in pathogen induced suppression
of early T cell activation (Fig. 4,5). It certainly also contributes to,
but not fully accounts for MV interference with p-tyr accumula-
tion and T cell expansion (Fig. 6). Possibly, identification of
specific p-tyr targets of MV (which are rescued upon NSM
knockdown, examples marked in Fig. 6A) would be informative in
delineating proteins activation of which is required in conferring
partial resistence of T cells to MV inhibition.
Materials and Methods
Ethics statement
Primary human cells were obtained from the Department of
Transfusion Medicine, University of Wu¨rzburg, and analysed
anonymously. All experiments involving human material were
conducted according to the principles expressed in the Declaration
of Helsinki and ethically approved by the Ethical Committee of
the Medical Faculty of the University of Wuerzburg.
Cells and virus
Primary human PBMCs were isolated from peripheral blood
obtained from healthy donors by Ficoll gradient centrifugation.
CD3+ T cells (purity $90%) were enriched from the PBMC
fraction using nylon wool columns and maintained in RPMI
1640/10% FCS. The MV wild-type strain WTF was grown on
human lymphoblastoid BJAB cells kept in RPMI 1640/10% FCS
and titrated on marmoset lymphoblastoid B95a cells. For exposure
experiments, MV (or MOCK preparation obtained from unin-
fected BJAB cells) was purified by sucrose gradient ultracentrifu-
gation. T cells were exposed to MV or a MOCK preparation in
the presence of a fusion inhibitory peptide (Z-D-Phe-L-Phe-
Gly-OH; 200 mM in DMSO; Bachem) to prevent infection of T
cells.
T cell stimulation and proliferation assay
16105 T cells when indicated pre-exposed to GW4869 (2 h,
1,3 mM), recombinant bacterial sphingomyelinase (30 mins,
12,5 mU/ml)(both: Sigma-Aldrich), MV or MOCK (each: 2 h
on ice) were pre-incubated with CD3- (clone UCHT-1) and/or
CD28-specific antibodies (clone CD28.2) (each 1 mg/ml)(both
Beckton-Dickinson Biosciences Pharmingen) on ice, subsequently
transferred onto 8-chamber slides for immunostaining (LabTekII,
Nunc) or 96 well plates (for proliferation assays) precoated with
25 mg/ml a-mouse IgG (Dianova) (1 h at 37uC) and stimulated for
the time intervals indicated at 37uC. For pseudo-IS formation,
26105 T cells were stimulated for 30 min at 37uC in 100 ml RPMI
1640/0,5% BSA with a-CD3/CD28-coated beads (Dynabeads
Human T-Activator CD3/CD28; Invitrogen) at a ratio of 4:1,
captured onto a poly-L-lysine-coated slides (LabTekII, Nunc) and
fixed at RT for 15 min in 4% PFA/PBS. For proliferation assays,
NSMKD or CTRL T cells exposed to MV or MOCK were
stimulated for 48 or 72 h including last 24 h labeling period ([3H]-
thymidine (Amersham)) and analyzed using a microplate scintil-
lation counter. For mixed leukocyte reaction with murine cells,
Smpd3-deficient splenocytes were isolated from Smpd3 knockout
fro/fro mice (or Smpd3-sufficient littermates) and co-cultured with
syngenic, superantigen-loaded bone marrow derived dendritic cells
(ratio 10:1) for 5 days.
Nucleofection and sphingomyelinase activity assay
Nucleofection of human T cells was performed according to the
manufacturer’s protocol (Amaxa) using pNSM2-GFP [48] (kindly
provided by Y. Hannun). 24 h following nucleofection, transfec-
tion efficiencies were determined by flow cytometry (the percent-
age of GFP+ cells ranged between 30 and 45%). For silencing of
NSM2, human T cells were nucleofected twice with a two days
interval with 400 pmol siRNA targeting human SMPD3 (NSM2)
[49] or, for control, a non-targeting siRNA (Sigma-Aldrich). Cell
aliquots were harvested at day 5 for activity assays. On average,
knockdown efficiencies were higher than 80% at enzyme activity
level (as exemplified in Fig. 1C). When indicated, cells were
exposed to dexamethasone (1025 M) (Sigma-Aldrich) or ETOH
(used as solvent) for 1 h. ASM or NSM activities were
determined as previously described [20] with modifications.
36106 T cells were disrupted by freeze/thawing (methanol/dry
ice) in ASM or NSM lysis buffer (pH 5.2 for ASM and pH 7.4
for NSM). Nuclei were removed by centrifugation for 5 min at
1600 rpm. Post-nuclear homogenate was centrifuged for 1 h at
26 000 rpm in PBS with protease inhibitors for detection of
NSM activity and in 100 mM Na-acetate, pH 5,2 for ASM. Cell
membrane extracts in ASM or NSM specific lysis buffer were
incubated with 1,35 mM HMU-PC (6-hexadecanoylamino-4-
methylumbelliferyl-phosphorylcholine) (Moscerdam substrates)
as an artificial sphingomyelinase substrate at 37uC for 17 h
(final volume 30 ml). Fluorescence reading was performed using
excitation at 404 nm and emission at 460 nm according to the
manufacturers protocol.
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Detection of ceramide, cytokines and Ca2+ fluxing by by
flow cytometry
For surface detection of ceramides, T cells were fixed with 1%
PFA/PBS for 15 min on ice after the indicated time intervals,
stained with primary (a-ceramide; clone MID15B4; Alexis
Biochemicals; 1 h, 4uC) followed by a secondary (30 min, 4uC)
antibody, and analyzed by flow cytometry (FACS Calibur; Becton
Dickinson).
Cytokines (IL-2, IL-4, IL-5, IL-10, IFN-c and TNF-a) were
detected in supernatants 4, 10, 24 and 72 h following aa˜CD3/
CD28 stimulation by cytometric bead assay (CBA) according to
the manufacturers instructions (human soluble protein flex sets;
BD Biosciences) using DIVA and FCAP Array Software. For
intracellular cytokine detection, cells were restimulated 72 h
following activation with 40 mM PMA/0,5 mM ionomycin for
4 h in the presence of 35 mM Brefeldin A (all: Sigma). Following a
mouse Ig bocking step, cells were stained with a-CD4 (Biolegend),
fixed and permeabilized prior to staining with antibodies specific
for IL-2 (Pharmingen), IL-10 (eBioscience) IFN-c and IL-17a
(both: BioLegend).
For Ca2+-mobilization experiments, T cells (16106) were
washed once and loaded with 1 mM Fluo-4 as cell-permanent
AM ester (Molecular Probes) in Hanks balanced salt solution
(without CaCl2, MgSO4, and phenol red) containing 5% FCS and
25 mM HEPES (pH 7.5) according to manufacturers’ protocol. a-
CD3 and a-CD28 antibodies (5 mg/ml) were added in complete
Hanks medium and Ca2+ flux was determined by flow cytometry.
Fluorescence microscopy
T cell activation was stopped by adding 4% PFA (in PBS) for
15 min, permeabilized with 0.1% Triton-X100 for 5 min, blocked
with 5% BSA and incubated with primary antibodies (a-ceramide,
a-LAT; FL-233; Santa Cruz) diluted in 1% BSA overnight at
4uC. Cells were stained with appropriate Alexa488-conjugated
secondary antibody (Invitrogen) for 45 min at RT. F-actin was
detected with 488 or 555 Fluorochrom-conjugated Phalloidin
(Cytoskeleton). Samples were mounted with Fluorochrome G
(Southern Biotech). Confocal Laser Scanning Microscopy
(CLSM) imaging was performed using a LSM 510 Meta (Zeiss,
Germany), equipped with an inverted Axiovert 200 microscope
and a 40x or 63x EC Plan-Apo oil objective (numerical aperture
1.3 or 1.4, respectively) and laser lines 488 and 543. Image
acquisition was performed with Zeiss LSM software 3.2 SP2.
When indicated, 0.15 mm thick z-stacks were acquired and 3–
dimensional reconstructed using LSM software or processed by
Huygens deconvolution software (SVI, Hilversum, The Nether-
lands). Quantification of cell area measurement was calculated
using the imaging processing program ImageJ (http://rsb.info.
nih.gov/ij/). For live analysis, 24 h following nucleofection of
pNSM2-GFP T cells were exposed to MV or MOCK, stimulated
with a-CD3/CD28-coated beads, subsequently transferred to 6-
channel m-slide VI (ibidi) and immediately imaged by confocal
microscopy.
Scanning Electron Microscopy (SEM)
For SEM, 36105 T cells were stimulated as described onto co-
stimulatory coverslips (12 mm) in a 24-well plate for the time
intervals indicated, fixed by addition of pre-warmed 6.25%
glutaraldehyde in 50 mM phosphate buffer (pH 7.2) for 10 min
at RT and subsequently at 4uC overnight. After a washing step,
samples were dehydrated stepwise in acetone, critical point dried
and sputtered with platin/paladium before SEM analysis (Jeol
JSM 7500 E).
Western blot analysis
36106 CTRL or NSMKD T cells were stimulated for the time
intervals indicated by cell-bound a-CD3/CD28 antibodies (1 mg/
ml each; Becton Dickinson) and plate-bound a-mouse IgG (25 mg/
ml; Dianova) in 12 well cell culture plate, lysed in 200 ml Western
blot sample buffer after freezing of samples by 280uC followed by
boiling for 5 min. p-tyr were detected using Mouse monoclonal
antibodies were used to detect tyrosine phosphorylated protein
species (p-tyr) (clone 4G10, Millipore), GAPDH, Akt (Santa Cruz),
p-Akt and pERK (both: Cell signaling). Quantification of signal
intensities was performed using AIDA software (Raytest).
Statistical analyses
Overall, data shown were acquired in at least three independent
experiments involving individual donors. For statistical analyses of
data sets, two-tailed Student’s t test (*p,0,05, **p ,0,005 and
***p,0,0005; ns: non significant) was used for throughout the
manuscript. Bars show standard deviations.
Supporting Information
S1 Figure A. Representative example of extrafacial
ceramide detection after 10 mins on T cells left untreated
(unstim) or stimulated with a-CD28, a-CD3 or a-CD3/
CD28.MFI (each upper right corner) and percentage of positive cells
are indicated. B. Basal ASM activity in T cell transfected with CTRL
(black bar) or NSM siRNA (white bar). C. Surface expression levels
(% positive cells, mean) of CD3 or CD28 were determined in CTRL
T cells (black bars, values set to 100%) and NSMKD T cells (grey
bars: CD3, white bars: CD28) by flow cytometry. A. and B: means of
three independent experiments are shown.
(TIF)
S2 Figure A. CTRL and NSMKD T cells seeded onto co-
stimulatory slides for 10 or 60 min were analyzed by
scanning electron microscopy. Overview, size bar: 10 mm. B.
CTRL or NSMKD T cells pre-exposed to MV or MOCK were
seeded onto co-stimulatory slides for 15 min, fixed and stained for
f-actin. Overview, size bar: 5 mm.
(TIF)
S3 Figure A. Ceramides (% positive cells, mean) were
detected on the surface of primary T cells left untreated
(set to 100%) or exposed to bacterial sphingomyelinase
or MV for 20 min by flow cytometry. B. Primary T cells
were exposed to dexamethasone (dex, 10-5 M) or the correspond-
ing amount of the solvent (ethanol) for 1 h and NSM activity levels
(left panel) and spreading responses on co-stimulatory slides after
15 min were determined (middle (f-actin staining) and right panels
(quantification of cell areas). size bar: 10 mm.
(TIF)
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